These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10234535)

  • 1. Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization.
    Berton M; Benimetskaya L; Allémann E; Stein CA; Gurny R
    Eur J Pharm Biopharm; 1999 Mar; 47(2):119-23. PubMed ID: 10234535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-modified PLGA nanoparticle delivery of triplex forming oligonucleotide for targeted prostate cancer therapy.
    Jiao J; Zou Q; Zou MH; Guo RM; Zhu S; Zhang Y
    Neoplasma; 2016; 63(4):569-75. PubMed ID: 27268920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles.
    Berton M; Turelli P; Trono D; Stein CA; Allémann E; Gurny R
    Pharm Res; 2001 Aug; 18(8):1096-101. PubMed ID: 11587479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of intracellular compartmentalization, trafficking and acidification of 5'-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells.
    Tonkinson JL; Stein CA
    Nucleic Acids Res; 1994 Oct; 22(20):4268-75. PubMed ID: 7937155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells.
    Iversen PL; Zhu S; Meyer A; Zon G
    Antisense Res Dev; 1992; 2(3):211-22. PubMed ID: 1490072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue.
    Iversen P
    Anticancer Drug Des; 1991 Dec; 6(6):531-8. PubMed ID: 1772568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles.
    Delie F; Berton M; Allémann E; Gurny R
    Int J Pharm; 2001 Feb; 214(1-2):25-30. PubMed ID: 11282232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes.
    Wingens M; van Hooijdonk CA; de Jongh GJ; Schalkwijk J; van Erp PE
    Arch Dermatol Res; 1998 Mar; 290(3):119-25. PubMed ID: 9558486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.
    Farokhzad OC; Jon S; Khademhosseini A; Tran TN; Lavan DA; Langer R
    Cancer Res; 2004 Nov; 64(21):7668-72. PubMed ID: 15520166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice.
    Zhao Q; Zhou R; Temsamani J; Zhang Z; Roskey A; Agrawal S
    Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):451-8. PubMed ID: 9918109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
    Zhao Q; Matson S; Herrera CJ; Fisher E; Yu H; Krieg AM
    Antisense Res Dev; 1993; 3(1):53-66. PubMed ID: 8495106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular localization of oligonucleotides: influence of fixative protocols.
    Pichon C; Monsigny M; Roche AC
    Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):89-93. PubMed ID: 10192293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides.
    Fattal E; Vauthier C; Aynie I; Nakada Y; Lambert G; Malvy C; Couvreur P
    J Control Release; 1998 Apr; 53(1-3):137-43. PubMed ID: 9741921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain.
    Liu Q; Shao X; Chen J; Shen Y; Feng C; Gao X; Zhao Y; Li J; Zhang Q; Jiang X
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):79-84. PubMed ID: 21163285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.
    Bennett CF; Mirejovsky D; Crooke RM; Tsai YJ; Felgner J; Sridhar CN; Wheeler CJ; Felgner PL
    J Drug Target; 1998; 5(3):149-62. PubMed ID: 9606005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
    Bennett CF; Chiang MY; Chan H; Shoemaker JE; Mirabelli CK
    Mol Pharmacol; 1992 Jun; 41(6):1023-33. PubMed ID: 1352033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of monensin PLGA polymer nanoparticles and liposomes as potentiator of ricin A immunotoxins in vitro.
    Ferdous AJ; Stembridge NY; Singh M
    J Control Release; 1998 Jan; 50(1-3):71-8. PubMed ID: 9685874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake and degradation of phosphorothioate oligonucleotides by marine and freshwater ciliates.
    Thomas LL; Price CM
    Antisense Res Dev; 1992; 2(3):251-6. PubMed ID: 1490074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxigenin-labeled phosphorothioate oligonucleotides: a new tool for the study of cellular uptake.
    Tarrasón G; Bellido D; Eritja R; Vilaró S; Piulats J
    Antisense Res Dev; 1995; 5(3):193-201. PubMed ID: 8785475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.